Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ranibizumab”

531 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 531 results

Post-approval studies (Phase 4)Study completedNCT02953938
What this trial is testing

Study to Show a Superior Benefit in Terms of Reduction of Ranibizumab Injections in Patients Receiving Ranibizumab Plus Laser Photocoagulation Combination Therapy Without Loss of Efficacy and Safety

Who this might be right for
Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)
Novartis Pharmaceuticals 59
Testing effectiveness (Phase 2)Study completedNCT01136252
What this trial is testing

Intravitreal Adalimumab in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationChoroidal Neovascularization
Hospital Universitari Vall d'Hebron Research Institute 5
Large-scale testing (Phase 3)Study completedNCT00470678
What this trial is testing

EXTEND III - Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)

Who this might be right for
Choroidal NeovascularizationAge-Related Macular Degeneration
Novartis 95
Not applicableStudy completedNCT01442064
What this trial is testing

An Extension Study to Evaluate Safety and Tolerability of Ranibizumab in Macular Edema Secondary to Retinal Vein Occlusion (Cohort 2)

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Genentech, Inc. 608
Not applicableUnknownNCT01303276
What this trial is testing

Retinal Blood Flow in Response to an Intravitreal Injection of Ranibizumab for Central Retinal Vein Occlusion (CRVO)

Who this might be right for
Central Retinal Vein Occlusion
University of Toronto 30
Not applicableUnknownNCT00640640
What this trial is testing

The Effects of Bevacizumab and Ranibizumab on Ocular Pulse Amplitude in Neovascular Age Related Macular Degeneration (AMD)

Who this might be right for
Neovascular Age Related Macular Degeneration
Sheba Medical Center 60
Testing effectiveness (Phase 2)Study completedNCT01594281
What this trial is testing

Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)

Who this might be right for
Proliferative Diabetic Retinopathy (PDR)
Novartis Pharmaceuticals 107
Not applicableUnknownNCT02158624
What this trial is testing

Ranibizumab Treatment for Age-Related Macular Degeneretion

Who this might be right for
Visual Disorder Due to Age-related Macula Degeneration
Kyushu University 100
Testing effectiveness (Phase 2)Study completedNCT00815360
What this trial is testing

Ranibizumab and Peripheral Scatter Laser in Patients With Diabetic Macular Edema and Peripheral Nonperfusion

Who this might be right for
Diabetic Macular Edema
Retina Associates of Florida, P.A. 22
Large-scale testing (Phase 3)Study completedNCT01661946
What this trial is testing

Bloodstream Absorption of Avastin and Lucentis After Injection Into the Eye

Who this might be right for
Diabetic Macular Edema
Queen's University 10
Large-scale testing (Phase 3)Study completedNCT00251459
What this trial is testing

Evaluate Ranibizumab in Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)

Who this might be right for
Choroidal NeovascularizationAge-related Macular Degeneration
Genentech, Inc. 5,000
Testing effectiveness (Phase 2)UnknownNCT01123564
What this trial is testing

Efficacy and Safety of Lucentis for Clinically Significant Macular Edema Secondary to Central Retinal Vein Occlusion

Who this might be right for
Retinal Vein OcclusionMacular Edema
University of Pecs 40
Testing effectiveness (Phase 2)Ended earlyNCT01025232
What this trial is testing

Intravitreal Injections of 2.0mg Ranibizumab in Subjects With Chronic Fluid On OCT Post Multiple Injections With Ranibizumab (Super-dose Anti-VEgf SAVE Trial)

Who this might be right for
Age Related Macular DegenerationChoroidal Neovascular MembraneSubfoveal Neovascular Age-Related Macular Degeneration+2 more
David M. Brown, M.D. 88
Large-scale testing (Phase 3)WithdrawnNCT03784443
What this trial is testing

Combined Ranibizumab and Iluvien for Diabetic Macular Oedema

Who this might be right for
Diabetic Macular EdemaDiabetes
Imperial College London
Not applicableUnknownNCT00455871
What this trial is testing

Study of Treatment Effects of Combination Therapy of Lucentis Plus Reduced Fluence PDT With Visudyne in Patients With Exudative AMD

Who this might be right for
Age-Related Macular Degeneration
Barnes Retina Institute 30
Testing effectiveness (Phase 2)Study completedNCT00504400
What this trial is testing

Ranibizumab to Treat Type 2 Idiopathic Macular Telangiectasia (RAMA-Trial)

Who this might be right for
Type 2 Idiopathic Macular Telangiectasia
University Hospital, Bonn 10
Testing effectiveness (Phase 2)Study completedNCT01003106
What this trial is testing

Ranibizumab DosE Comparison and the Role of LAser in REtinal Vein Occlusions

Who this might be right for
Retinal Vein Occlusion
Peter A Campochiaro, MD 81
Not applicableStudy completedNCT05576792
What this trial is testing

A 24-week Study Evaluating the Effectiveness and Safety of Lucentis® 0.2mg in Retinopathy of Prematurity Participants in China

Who this might be right for
Retinopathy of Prematurity
Novartis Pharmaceuticals 62
Testing effectiveness (Phase 2)Study completedNCT01292798
What this trial is testing

Ranibizumab 0.5mg and 2.0mg to Treat Diabetic Macular Edema in Patients With Poor Response to Bevacizumab

Who this might be right for
Diabetic Macular Edema
California Retina Consultants 43
Testing effectiveness (Phase 2)Study completedNCT02859441
What this trial is testing

A Phase I/II Trial for Intravitreous Treatment of Severe Ocular Von Hippel-Lindau Disease Using a Combination of the PDGF Antagonist E10030 and the VEGF Antagonist Ranibizumab

Who this might be right for
Von Hippel-Lindau Syndrome
National Eye Institute (NEI) 3
Load More Results